Author:
Rajaram Gayathri,Alagaraswamy Alagumurugan,Subramanian Muthukumar,Ravi Vinesha
Abstract
Cancer is undeniably a scary disease that leads to morbidity and mortality. With the state-of-the-art advances, chemotherapy has made incredible strides, but the efficiency is still questionable. Diagnosing and treating cancer are necessary to effectively approach the disease. Theranostics is a hybrid technique that combines therapeutics and diagnostics. The key to cancer therapy is targeted drug delivery, which specifically kills cancer cells without harming healthy cells. The idea of targeted therapy is merely a theoretical expectation that the drug will reach the target site. As seeing is believing, theranostics helps visualize the drug delivery with the combination of diagnostic agents. Clinical settings have extensively examined the field of theranostics. This chapter goes into great length about the potential targets and radioisotopes in theranostics.
Reference77 articles.
1. Wu S, Zhu W, Thompson P, Hannun YA. Evaluating intrinsic and non-intrinsic cancer risk factors. Nature Communications. 2018;9(1):3490
2. Internet Source – Cancer, WHO Factsheets. Available from: https://www.who.int/news-room/factsheets/detail/cancer#:~:text=Tobacco%20use%2C%20alcohol%20consumption%2C%20unhealthy,%2D%20and%20middle%2Dincome%20countries [Accessed: April 16, 2023]
3. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):17-48
4. Park W, Heo YJ, Han DK. New opportunities for nanoparticles in cancer immunotherapy. Biomaterial Research. 2018;22:24
5. Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: Current progress and challenges. Nanoscale Research Letters. 2021;16:173